Skip to main content
Log in

The protein binding of some drugs in plasma from patients with alcoholic liver disease

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The binding of 5 drugs to plasma proteins from patients with alcoholic liver disease has been studied by in vitro techniques and compared to that from normal subjects. The binding of quinidine is decreased in such patients. For this reason, if in patients with alcoholic liver disease treated for coincidental arrhythmias with quinidine, plasma quinidine concentrations are measured, allowance for the decreased binding must be made in interpreting the concentration measurements. Diphenylhydantoin binding was normal or near normal in most of the patients' plasma samples. The other drugs tested, fluorescein, dapsone, and triamterene, had decreased binding in the patients' plasma samples.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Koch-Weser, J.: Serum drug concentrations as therapeutic guides. New Engl. J. Med.287 227–231 (1972)

    Google Scholar 

  2. Reidenberg, M.M., Affrime, M.: Influence of disease on binding of drugs to plasma proteins. Ann. N.Y. Acad. Sci.226 115–126 (1973)

    Google Scholar 

  3. Solow, E.B., Green, J.B.: The simultaneous determination of multiple anticonvulsant drug levels by gas-liquid chromatography. Neurology22 540–550 (1972)

    Google Scholar 

  4. Borondy, P., Dill, W.A., Chang, T., Buchanan, R.A., Glazko, A.J.: Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells. Ann. N.Y. Acad. Sci.226 82–87 (1973)

    Google Scholar 

  5. Lunde, P.K.M., Rane, A., Yaffe, S.J., Lund, L., Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in man. Clin. Pharmacol. Ther.11 846–855 (1970)

    Google Scholar 

  6. Wilkinson, G.R., Kurata, D.: The uptake of diphenylhydantoin by the human erythrocyte and its application to the estimation of plasma binding. In: Drug interaction, pp. 289–297. (Morselli, P.L., Garattini, S., Cohen, S.N., Eds.). New York: Raven Press 1974

    Google Scholar 

  7. Galvão-Teles, A., Burke, C.W., Anderson, D.C., Marshall, J.C., Corker, C.S., Brown, R.L., Clark, M.L.: Biologically active androgens and oestradiol in men with chronic liver disease. Lancet 1973I 173–177

    Google Scholar 

  8. Breuer, V.J., Schneider, H.T., Breuer, H.: Untersuchungen über die Bindung von Testosteron und Östradiol-17β durch Serumproteine bei Normalpersonen und bei Patienten mit Lebercirrhose. Z. klin. Chem.8 626–631 (1970)

    Google Scholar 

  9. Powell, L.W., Axelson, E.: Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut13 690–696 (1972)

    Google Scholar 

  10. Hooper, W.D., Bochner, F., Eadie, M.J., Tyrer, J.H.: Plasma protein binding of diphenylhydantoin. Clin. Pharmacol. Ther.15 276–282 (1974)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by grants (GM 18279 and RR349) from the U.S. Public Health Service and a grant from the Smith, Kline, and French Foundation.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Affrime, M., Reidenberg, M.M. The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol 8, 267–269 (1975). https://doi.org/10.1007/BF00567126

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00567126

Key words

Navigation